JD LYMON Group
JD LYMON Group is a boutique U.S. market access consulting firm serving medical technology and biopharmaceutical companies, providing reimbursement strategy, coding, CMS policy engagement, and coverage consulting across the product lifecycle to startups and Fortune 500 clients.
- Company typePrivate
- Founded2007
- HeadquartersMendota, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What JD LYMON Group does
JD LYMON Group is a privately-held, boutique market access consulting firm headquartered in Mendota Heights, Minnesota (Minneapolis metro), founded in 2007 and operating with five partners and a small total headcount. The firm serves U.S. medical technology and biopharmaceutical companies across the full lifecycle of market access — from founders validating reimbursement pathways for prototypes to commercial teams optimizing coverage for marketed products. Its client base spans venture-backed startups, growth-stage MedTech companies, and Fortune 500 organizations, with named engagements including sleep apnea startups (ShiraTronics) and international MedTech companies entering the U.S. market (Nyxoah).
The firm's service portfolio consists of nine defined consulting offerings: reimbursement landscape assessments, CMS policy engagement, coding application development and submission (CPT, ICD-10, HCPCS), incremental Medicare payment applications (NTAP, TPT, New Technology APCs, intraocular lens payment mechanisms), medical society engagement, coverage landscape overview, evidence review and generation planning, trial design and analysis, and clinical trial budget development. Delivery is built on the individual expertise of five partners — Jolayne Devers, Mark Domyahn, Carla Monacelli, John McInnes, and Amanda Cassidy — who collectively bring 125+ years of MedTech reimbursement experience spanning CMS, major device companies (Medtronic, Allergan, Zimmer, Nevro, LivaNova), and top healthcare law/policy firms (Arnold & Porter).
JD LYMON generates revenue through professional services engagements on a project or retainer basis, priced by scope and complexity with no public pricing disclosure. Go-to-market relies on a single-country (United States) direct enterprise consulting motion, with lead generation through the firm's website, LinkedIn presence of its partners, industry conference participation, and referral-driven business development within the healthcare consulting network. There is no proprietary technology platform, no AI/ML offering, no disclosed funding, and no parent company or institutional investors identified.
JD LYMON Group firmographics
Firmographics- Name
- JD LYMON Group
- Legal name
- JD Lymon Group
- Website
- https://jdlymon.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- JD LYMON Group is a boutique U.S. market access consulting firm serving medical technology and biopharmaceutical companies, providing reimbursement strategy, coding, CMS policy engagement, and coverage consulting across the product lifecycle to startups and Fortune 500 clients.
- Ownership category
- akta.pro rank
JD LYMON Group industry classification
Industry- Product category
- Healthcare Market Access Consulting
- NAICS
- Management Consulting Services (54161), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Management Services (8741), Services-Health Services (8000)
- akta.pro primary industry
- DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA) (HLACANAN)
Keywords
Where JD LYMON Group is headquartered
LocationHeadquarters
- HQ city
- Mendota
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
JD LYMON Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Market Access Consulting Services: JD Lymon Group provides specialized consulting services to medical technology and biopharmaceutical companies. Their revenue is generated through consulting engagements that span the full lifecycle of U.S. market access strategy, including reimbursement landscape assessments, CMS policy engagement, coding applications, and coverage strategy development. Services are tailored to each client's specific technology and business needs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
JD LYMON Group product offering
Product offeringCore offering
JD LYMON Group is a specialized market access consulting firm serving medical technology and biopharmaceutical companies across the full U.S. reimbursement lifecycle. The firm delivers reimbursement landscape assessments, CMS policy engagement, coding applications (CPT/ICD-10/HCPCS), incremental Medicare payment applications (NTAP, TPT, New Technology APCs), medical society engagement, coverage analysis, evidence generation planning, trial design review, and clinical trial budget development.
Product overview
JD Lymon Group is a specialized market access consulting firm offering a portfolio of reimbursement strategy services for MedTech and biopharmaceutical companies. The company provides nine distinct consulting service offerings spanning the full lifecycle of U.S. market access strategy, including reimbursement landscape assessments, CMS policy engagement, coding applications, incremental Medicare payment applications, medical society engagement, coverage landscape analysis, evidence generation planning, trial design, and clinical trial budget development. The firm serves four primary market segments: Medical Devices, Durable Medical Equipment (DME), SaaS and Digital Health Technologies, and Biologics and Orphan Therapies. The services are tailored to clients ranging from venture-backed startups to Fortune 500 organizations, addressing the interrelationships among health policy, reimbursement, and commercial execution.
Differentiator
Problem solved
Functional benefit
Products and services
- Reimbursement landscape assessments
Quantifiable outcome
- Successfully established numerous Medicare payment mechanisms and obtained CPT, ICD-10, and HCPCS codes for emerging technologies
- +1 more outcomes
Companies that use JD LYMON Group
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles2 records
JD LYMON Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
JD LYMON Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- NyxoahcoreJD Lymon Group serves as an independent reimbursement consulting partner to Nyxoah, a Belgian medical technology company focused on obstructive sleep apnea solutions. At Nyxoah's Investor and Analyst Day, JD Lymon Group presents on the U.S. reimbursement landscape and the company's path to profitability for the Genio system launch. This represents an ongoing consulting engagement supporting U.S. commercial execution and market access strategy.
- ShiraTronicscoreJD Lymon Group has worked with ShiraTronics, a venture-backed startup developing sleep apnea treatment devices, starting from the late development phase through the clinical phase. The firm has helped position the company for commercial launch with unique codes and a well-understood strategy for future payment and coverage, demonstrating their involvement in shaping market access strategy for emerging medical technologies.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
JD LYMON Group competitors and assessment
Company assessmentDirect peers
- Health Advances: Health Advances is a strategy consulting firm for MedTech and biopharma, with explicit practice areas in reimbursement strategy, market access, and payer engagement. Its service model and client base closely mirror JD LYMON's.
- Avalere Health: Avalere is a healthcare policy and market access consulting firm serving MedTech, biopharma, and health plan clients. It overlaps directly with JD LYMON in CMS policy engagement, coverage strategy, and reimbursement advisory, though it operates at a significantly larger scale.
- Evidera (PPD, Thermo Fisher): Evidera provides evidence generation, health economics, and market access consulting for life sciences manufacturers. It overlaps with JD LYMON's evidence review and generation planning as well as payer-facing strategy work.
- Boston Healthcare Associates: Boston Healthcare Associates provides market access, reimbursement, and health economics consulting for medical device and biopharmaceutical manufacturers. It is one of the closest direct competitors in the medical device reimbursement strategy niche.
- Xcenda (Cencora): Xcenda is a market access and reimbursement consulting arm of Cencora (formerly AmerisourceBergen), serving life sciences manufacturers. It competes directly with JD LYMON on coding, coverage, and payer strategy for medical devices and specialty therapeutics.
- MCRA (Medical Device Regulatory Advisors): MCRA is a medical device-focused consulting firm spanning reimbursement, regulatory, and clinical research services. It directly competes with JD LYMON's CMS policy engagement and coding/payment work for MedTech clients.
Broad incumbents
- ZS Associates: ZS Associates is a large global consulting firm with a substantial healthcare and market access practice serving pharma and MedTech. While broader in scope than JD LYMON, it competes for the same enterprise reimbursement strategy mandates.
- Huron Consulting Group: Huron is a large consulting firm with a healthcare practice covering strategy, operations, and revenue cycle/reimbursement advisory for providers and MedTech. It competes for larger reimbursement engagements that JD LYMON cannot fully staff.
- Simon-Kucher & Partners: Simon-Kucher is a global consulting firm with a life sciences practice covering pricing, market access, and reimbursement strategy. It competes with JD LYMON for biopharma and MedTech reimbursement engagements, especially for larger enterprise clients.
Emerging players
- Argenta Advisors: Argenta Advisors was a healthcare consulting firm co-founded by JD LYMON partner Carla Monacelli. It is a historical peer and partially overlapping service offering in reimbursement and government affairs consulting for life sciences.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
JD LYMON Group social profiles
Digital presenceJD LYMON Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
JD LYMON Group leadership team
Management profileNumber of profiles
Profiles5 records
JD LYMON Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JD LYMON Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JD LYMON Group
What does JD LYMON Group do?
JD LYMON Group is a specialized market access consulting firm serving medical technology and biopharmaceutical companies across the full U.S. reimbursement lifecycle. The firm delivers reimbursement landscape assessments, CMS policy engagement, coding applications (CPT/ICD-10/HCPCS), incremental Medicare payment applications (NTAP, TPT, New Technology APCs), medical society engagement, coverage analysis, evidence generation planning, trial design review, and clinical trial budget development.
Is JD LYMON Group a public or private company?
JD LYMON Group is a private company. It is classified as management employee owned and is currently operating.
When was JD LYMON Group founded?
JD LYMON Group was founded in 2007. It employs 1 to 10 people.
Where is JD LYMON Group based?
JD LYMON Group is headquartered in Mendota, United States, in the North America region.
How does JD LYMON Group make money?
One revenue line is on record: market Access Consulting Services.
Who are JD LYMON Group's main competitors?
Direct peers on record are Health Advances, Avalere Health, Evidera (PPD, Thermo Fisher), Boston Healthcare Associates, Xcenda (Cencora) and MCRA (Medical Device Regulatory Advisors). Broad incumbents are ZS Associates, Huron Consulting Group and Simon-Kucher & Partners. Argenta Advisors is listed as an emerging player.
Does JD LYMON Group have an API?
No public API is recorded for JD LYMON Group.
What industry is JD LYMON Group in?
JD LYMON Group's product category is Healthcare Market Access Consulting. Its primary akta.pro industry code is HLACANAN, DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA). Its NAICS code is 54161 and its SIC code is 8741.